Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00100100 · ClinicalTrials.gov registry record · Phase 2
Modafinil for the Treatment of Cocaine Dependence - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT00100100 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 210 participants.
The verdict
NCT00100100, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00100100
The ClinicalTrials.gov registry entry for NCT00100100 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT00100100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00100100 about?
NCT00100100 is a clinical study titled "Modafinil for the Treatment of Cocaine Dependence - 1". The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
What is the current status of trial NCT00100100?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2004-10. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00100100?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00100100?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.